Utility values mapped from MSQ | Linear mixed effects model with REML | Fractional response model (logit) | Fractional response model (probit) | Beta regression | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coeff | 95% CI | p value | Coeff | 95% CI | p value | Coeff | 95% CI | p value | Coeff | 95% CI | p value | |||||
Erenumab 70 mg (vs placebo) | 0.006 | −0.004 | 0.016 | 0.212 | 0.0331 | −0.015 | 0.814 | 0.178 | 0.020 | − 0.089 | 0.048 | 0.176 | 0.023 | −0.023 | 0.068 | 0.335 |
Erenumab 140 mg (vs placebo) | 0.015 | 0.004 | 0.026 | 0.007 | 0.0744 | 0.023 | 0.125 | 0.004 | 0.044 | 0.0139 | 0.074 | 0.004 | 0.061 | 0.014 | 0.109 | 0.011 |
Baseline MMD | 0.0017 | −0.003 | −0.001 | <  0.001 | 0.0001 | − 0.005 | 0.005 | 0.970 | −0.0004 | −0.004 | 0.003 | 0.806 | −0.002 | −0.007 | 0.004 | 0.557 |
MMD | −0.015 | −0.016 | −0.015 | <  0.001 | −0.077 | −0.082 | − 0.072 | <  0.001 | − 0.047 | − 0.049 | − 0.044 | <  0.001 | − 0.074 | − 0.079 | − 0.069 | < 0.001 |
Visit | ||||||||||||||||
 Week 4 | 0.037 | 0.033 | 0.042 | <  0.001 | 0.167 | 0.141 | 0.193 | <  0.001 | 0.101 | 0.086 | 0.117 | <  0.001 | 0.160 | 0.133 | 0.187 | < 0.001 |
 Week 8 | 0.038 | 0.033 | 0.426 | <  0.001 | 0.173 | 0.144 | 0.202 | <  0.001 | 0.104 | 0.087 | 0.122 | <  0.001 | 0.164 | 0.134 | 0.194 | < 0.001 |
 Week 12 | 0.038 | 0.033 | 0.042 | <  0.001 | 0.176 | 0.145 | 0.206 | <  0.001 | 0.106 | 0.087 | 0.124 | <  0.001 | 0.165 | 0.134 | 0.197 | < 0.001 |
 Week 16 | 0.032 | 0.026 | 0.038 | <  0.001 | 0.194 | 0.153 | 0.235 | <  0.001 | 0.115 | 0.091 | 0.139 | <  0.001 | 0.178 | 0.138 | 0.217 | < 0.001 |
 Week 20 | 0.030 | 0.024 | 0.036 | <  0.001 | 0.187 | 0.148 | 0.227 | <  0.001 | 0.111 | 0.087 | 0.134 | <  0.001 | 0.170 | 0.133 | 0.209 | < 0.001 |
 Week 24 | 0.028 | 0.022 | 0.035 | <  0.001 | 0.185 | 0.144 | 0.227 | <  0.001 | 0.109 | 0.085 | 0.134 | <  0.001 | 0.169 | 0.129 | 0.209 | < 0.001 |
Age | 0.0004 | 0.0002 | 0.0008 | <  0.001 | 0.002 | −7.11e−06 | 0.004 | 0.051 | 0.001 | 0.000 | 0.002 | 0.044 | 0.002 | −0.001 | 0.003 | 0.074 |
Female | −0.015 | −0.027 | − 0.003 | 0.011 | −0.082 | −0.140 | −0.024 | 0.006 | −0.048 | −0.082 | −0.014 | 0.006 | −0.077 | −0.130 | −0.024 | 0.004 |
Race (vs white) | ||||||||||||||||
 Black | −0.013 | −0.030 | 0.004 | 0.140 | −0.054 | −0.139 | 0.032 | 0.217 | − 0.033 | −0.083 | 0.018 | 0.205 | −0.050 | −0.130 | 0.030 | 0.221 |
 Other | −0.022 | −0.049 | 0.005 | 0.104 | −0.129 | −0.282 | 0.024 | 0.099 | −0.077 | −0.168 | 0.135 | 0.095 | −0.109 | −0.257 | 0.039 | 0.148 |
RMSE | 0.115 | 0.114 | 0.114 | 0.114 | ||||||||||||
MAE | 0.086 | 0.085 | 0.085 | 0.085 |